Work Here?
Overview
HealthMatch is a digital platform that connects patients with suitable clinical trials worldwide. It maintains a comprehensive database of trials across medical conditions and provides a user-friendly interface for patients to search and enroll. Sponsors and healthcare organizations partner with HealthMatch to find participants, enabling revenue through these partnerships. Unlike generic job-matching sites, HealthMatch focuses on clinical trial recruitment and uses global reach to match patients with appropriate studies efficiently. The company’s goal is to accelerate medical research and the development of new treatments by increasing patient participation in clinical trials.
About HealthMatch
Industries
Data & Analytics
Healthcare
Company Size
11-50
Company Stage
Series C
Total Funding
$25.8M
Headquarters
Sydney, Australia
Founded
2017
Get referred to HealthMatch
See people who can refer or advise you
Simplify's Take
What believers are saying
- HealthMatch closed a $10 million Series C in March 2025, funding U.S. expansion.
- Its site-sponsor offering targets research sites needing centralized recruitment across portfolios.
- Updated 2026 pages and affiliate outreach show the company is still actively selling.
What critics are saying
- HealthMatch cut half its staff in June 2022, signaling weak operating leverage.
- Antidote, Tempus, ConcertAI, and Inato compress pricing and steal sponsor attention now.
- If sponsor revenue stalls again, HealthMatch becomes an acquisition target or shuts down.
What makes HealthMatch unique
- HealthMatch owns patient-facing trial search, plus sponsor and site recruitment workflows.
- Its 2026 site-sponsor product adds CTMS integration and performance-based pricing.
- The platform still shows 300+ actively enrolling studies, sustaining consumer and sponsor demand.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$25.8M
Below
Industry Average
Funded Over
4 Rounds
Industry standards
Benefits
Remote Work Options
Company Equity
Growth & Insights and Company News
6 month growth
↓ -7%1 year growth
↓ -7%2 year growth
↓ -7%Clinical trials access startup HealthMatch has raised $10 million in Series C. The round was led by the company’s original backer, Folklore Ventures. Paul Bassat’s Square Peg Capital led an $18 million Series B in the Sydney-based startup in December 2020, also invested in the Series C. Square Peg also led a $6 million series A in late 2019. Malcolm and Lucy Turnbull and Tempus Partners are among the previous investors in HealthMatch, which uses machine learning to automate clinical trials for contract research companies
Officially launched in 2019, HealthMatch has raised A$25 million in venture capital from investors across Australia, the US and Singapore (where the company received the largest local health tech funding round in Australia for 2020), making access to emerging potential treatments much easier for patients.
HealthMatch is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
About HealthMatch
Industries
Data & Analytics
Healthcare
Company Size
11-50
Company Stage
Series C
Total Funding
$25.8M
Headquarters
Sydney, Australia
Founded
2017
HealthMatch is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today